Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Raw Materials (2016 - 2022)

Historic Raw Materials for Usana Health Sciences (USNA) over the last 12 years, with Q3 2022 value amounting to $24.6 million.

  • Usana Health Sciences' Raw Materials fell 940.22% to $24.6 million in Q3 2022 from the same period last year, while for Jul 2022 it was $24.6 million, marking a year-over-year decrease of 940.22%. This contributed to the annual value of $30.3 million for FY2022, which is 689.07% up from last year.
  • Per Usana Health Sciences' latest filing, its Raw Materials stood at $24.6 million for Q3 2022, which was down 940.22% from $30.6 million recorded in Q2 2022.
  • Usana Health Sciences' Raw Materials' 5-year high stood at $30.9 million during Q4 2021, with a 5-year trough of $14.1 million in Q1 2020.
  • Moreover, its 5-year median value for Raw Materials was $22.5 million (2019), whereas its average is $23.6 million.
  • Per our database at Business Quant, Usana Health Sciences' Raw Materials crashed by 3707.92% in 2020 and then soared by 9329.02% in 2021.
  • Over the past 5 years, Usana Health Sciences' Raw Materials (Quarter) stood at $19.5 million in 2018, then decreased by 18.58% to $15.9 million in 2019, then surged by 42.13% to $22.6 million in 2020, then soared by 37.05% to $30.9 million in 2021, then decreased by 20.37% to $24.6 million in 2022.
  • Its Raw Materials was $24.6 million in Q3 2022, compared to $30.6 million in Q2 2022 and $30.3 million in Q1 2022.